Pharmafile Logo
Pharmafocus logo
Advanced Search
Janssen image

Janssen psoriasis drug beats placebo

March 25, 2014
Research and Development, Sales and Marketing Janssen, dermatology, guselkumab

News
sanofi

Final no for Sanofi’s Zaltrap

March 25, 2014
Medical Communications, Sales and Marketing NICE, Sanofi, Zaltrap, colorectal cancer

News
elizabeth_kuiper_efpia

EFPIA hires director of European affairs

March 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, kuiper

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Elizabeth Kuiper to be the director of its European …

Appointment

Parexel expands international operation

March 25, 2014
Manufacturing and Production, Sales and Marketing Parexel, Singapore, manufacturing

Biopharma services provider Parexel International Corporation is beefing up its global capacity and adding more secondary packaging and labelling services …

News

Xolair gets FDA approval for skin condition

March 24, 2014
Research and Development, Sales and Marketing FDA, Novartis, Roche, Sanofi, Xolair, chronic hives, csu

 An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …

News

CHMP recommends Jardiance

March 24, 2014
Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly

Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …

News
MSD image

Endocyte lung cancer drug shows promise

March 24, 2014
Research and Development, Sales and Marketing Endocyte, MSD, NSCLC, lung cancer, vintafolide

Endocyte and partner MSD have released positive mid-stage trial results for their investigational lung cancer drug vintafolide. The treatment met …

News
xofigo_bayer

NICE says ‘no’ to Xofigo

March 24, 2014
Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo

NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …

News
jenny_cowderoy

Former Google head to lead comms for M3


March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cowderoy, doctors.net, google, m3

Healthcare information provider M3 has appointed the former head of healthcare at Google as its managing director of communications in …

Appointment
EU flag image

Data transparency debate: Europe decides its future

March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency

Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …

Feature
Velcade image

NICE approves Velcade

March 21, 2014
Sales and Marketing Janssen, NHS, NICE, Velcade, myeloma

NICE has recommended Janssen’s proteasome inhibitor Velcade as an induction treatment for some patients with newly-diagnosed multiple myeloma. The draft …

News
Supercomputer image

IBM supercomputer could hold key to brain cancer

March 21, 2014
Medical Communications, Sales and Marketing avastin, brain cancer, ibm, nygc, supercomputer

The New York Genome Center and IBM Watson have joined forces to accelerate a new era of genomic medicine, initially …

News
dave_piacquad

Amgen names senior VP of Business Development

March 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, David Piacquad

Amgen has confirmed the appointment of David Piacquad to the new position of senior vice president of its Business Development …

Appointment
EMA image

EMA launches speedy pilot

March 21, 2014
Sales and Marketing BIA, EMA, MHRA, NICE, early access, trials

The European Medicines Agency (EMA) has launched an initiative aimed at speeding up the drug approval process and wants help …

News
Cairns image

AstraZeneca banks on MasterCard for director

March 20, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Johansson, ann cairns, british gas, mastercard

AstraZeneca is proposing to elect the president of International Markets for MasterCard to stand as a non-executive director on its …

News
Vodaphone image

AstraZeneca signs Vodafone contract

March 20, 2014
Medical Communications, Sales and Marketing AstraZeneca, cardiovascular, mhealth, vodaphone

AstraZeneca has signed up with phone operator Vodafone to provide mobile health (mHealth) services for patients suffering from cardiovascular issues. …

News
GSK image

GSK cancer vaccine fails again

March 20, 2014
Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma

GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials.  The …

News
george_osborne_budget_day_2014

BIA welcomes budget statement

March 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme

An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …

News
screen_shot_2014-03-20_at_07

Takeda hires head of emerging markets

March 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, giles platford

Giles Platford has been appointed head of commercial operations, emerging markets for Swiss-based pharma firm Takeda. Reporting to its chief …

Appointment
FDA image

FDA ‘not trusted’ by Americans

March 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, JAMA, MMR, US, america, conspiracy, yougov

More than one-third of Americans in a new survey think the Food and Drug Administration is holding back new cures …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026